Search research articles
Contact Us
Filters
Showing results (91-100 of 178) with videos related to
Page
of 18
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2009
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies
Mehdi Hamadani, William Blum, Gary Phillips, et al.
Leukemia & Lymphoma
|
July 4, 2015
Tocilizumab for steroid refractory acute graft-versus-host disease
Julianna V F Roddy, Bradley M Haverkos, Ali McBride, et al.
Multiple Sclerosis and Related Disorders
|
July 20, 2021
Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis
Hyunwoo Lee, Kunio Nakamura, Sridar Narayanan, et al.
Blood Advances
|
June 16, 2023
Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor
Zachary D Crees, Michael P Rettig, Asad Bashey, et al.
PLOS Digital Health
|
February 22, 2023
Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2)
William A Wood, Deepika Dilip, Andriy Derkach, et al.
Haematologica
|
May 13, 2010
Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias
William Blum, Mitch A Phelps, Rebecca B Klisovic, et al.
British Journal of Haematology
|
May 12, 2010
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation
Kristie A Blum, Zhongfa Liu, David M Lucas, et al.
Blood
|
April 30, 2011
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts
Claudio G Brunstein, Ephraim J Fuchs, Shelly L Carter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 23, 2005
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients
Hillard M Lazarus, Omer N Koc, Steven M Devine, et al.
Transplantation and Cellular Therapy
|
April 20, 2024
Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance
Mark A Murakami, Laura Connelly-Smith, Thomas Spitzer, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 178) with videos related to
Sort By:
Page
of 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2009
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies
Mehdi Hamadani, William Blum, Gary Phillips, et al.
Leukemia & Lymphoma
|
July 4, 2015
Tocilizumab for steroid refractory acute graft-versus-host disease
Julianna V F Roddy, Bradley M Haverkos, Ali McBride, et al.
Multiple Sclerosis and Related Disorders
|
July 20, 2021
Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis
Hyunwoo Lee, Kunio Nakamura, Sridar Narayanan, et al.
Blood Advances
|
June 16, 2023
Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor
Zachary D Crees, Michael P Rettig, Asad Bashey, et al.
PLOS Digital Health
|
February 22, 2023
Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2)
William A Wood, Deepika Dilip, Andriy Derkach, et al.
Haematologica
|
May 13, 2010
Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias
William Blum, Mitch A Phelps, Rebecca B Klisovic, et al.
British Journal of Haematology
|
May 12, 2010
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation
Kristie A Blum, Zhongfa Liu, David M Lucas, et al.
Blood
|
April 30, 2011
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts
Claudio G Brunstein, Ephraim J Fuchs, Shelly L Carter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 23, 2005
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients
Hillard M Lazarus, Omer N Koc, Steven M Devine, et al.
Transplantation and Cellular Therapy
|
April 20, 2024
Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance
Mark A Murakami, Laura Connelly-Smith, Thomas Spitzer, et al.
Page
of 18